Professor Henk van der Poel is head of the department of urology at the Netherlands Cancer Center in Amsterdam (NL) and endowed-professor the Free-University, Amsterdam (NL). Main focuses of research are the role of image-guided surgery in the management of urological oncological diseases and the perioperative network cancer-care for prostate cancer. He is editor-in-chief of the Dutch Journal of Urology.

David F. Penson, MD, MPH is the Hamilton and Howd Chair in Urologic Oncology, Director of the Center for Surgical Quality and Outcomes Research and Professor and Chair, Department of Urology at Vanderbilt University Medical Center. He obtained his MD from Boston University and completed his urology residency at UCLA Medical Center in Los Angeles. He then was awarded a Robert Wood Johnson Clinical Scholar fellowship at Yale University and also obtained an MPH at Yale. He currently maintains a clinical practice in urologic oncology at the Vanderbilt-Ingram Cancer Center. His specific research interests include the comparative effectiveness of treatment options in localized prostate cancer and the impact of the disease and its treatment on patients’ quality of life. He has received federal grant funding from the National Cancer Institute, the US Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention and the Patient-Centered Outcomes Research Institute. His work has been published in various high-profile journals, including the New England Journal of Medicine, JAMA and the Annals of Internal Medicine. He previously chaired the National Institutes of Health’s Health Services Outcomes and Delivery (HSOD) study section, which reviews almost all health services research grant submitted to the NIH. He also maintains a strong interest in health policy and quality improvement. He currently serves as the Secretary of the American Urological Association.

Dr Andrew Loblaw is a Radiation Oncologist, Clinician Scientist, and dual Professor in the Department of Radiation Oncology and the Institute of Health Policy Management & Evaluation at the University of Toronto. He’s the Site Group Co-Lead for Genitourinary Oncology at Sunnybrook. He received a Bachelor of Science in Physics from the University of British Columbia and his Doctor of Medicine from Queen’s University. He completed his specialty training in Radiation Oncology concurrent with a Masters degree in Clinical Epidemiology to graduate from the Royal College’s Clinician Investigator Program all at the University of Toronto. Dr Loblaw’s clinical practice and research interest focus on improving outcomes for men with prostate cancer and the healthcare system. He has a particularly interest in the design and conduct of clinical trials, the generation and dissemination of evidence-based guidelines and in image-guided radiotherapy. Dr Loblaw is an Ontario Association of Radiation Oncology Clinician Scientist and a Senior Scientist at the Sunnybrook Research Institute. A Fellow of the American Society of Clinical Oncology (FASCO), he was previous Co-Chair of the ASCO’s Genitourinary Advisory Group and remains Co-Chair of the GU group for Cancer Care Ontario’s Program in Evidence-Based Care. He has authored over 325 peer-reviewed papers and has been awarded grant funding of over Cdn$52M.

Kindly sponsored by


Prof. Tobias Maurer, FEBU, is a renowned urologist at the Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, with a clinical and scientific focus on prostate cancer, particularly in the fields of imaging, surgery, and medical therapy. He is a leading expert in PSMA-PET imaging and PSMA-radioguided surgery, with over 285 scientific publications and an h-index of 62. Prof. Maurer has served as principal or co-investigator in more than 30 clinical trials and has received over 30 national and international awards, including the DGU Research and Innovation Award for PSMA-radioguided surgery.

Kindly sponsored by


Prof. Tobias Maurer, FEBU, is a renowned urologist at the Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, with a clinical and scientific focus on prostate cancer, particularly in the fields of imaging, surgery, and medical therapy. He is a leading expert in PSMA-PET imaging and PSMA-radioguided surgery, with over 285 scientific publications and an h-index of 62. Prof. Maurer has served as principal or co-investigator in more than 30 clinical trials and has received over 30 national and international awards, including the DGU Research and Innovation Award for PSMA-radioguided surgery.

Urologist- Nepean Hospital Senior Clinical Lecturer- Sydney University

Urologist- Nepean Hospital Senior clinical lecturer- Sydney Medical School

Melissa Hadley Barrett Sexologist / Nurse Practitioner / Podcast Host / Clinic Director Melissa is an experienced Australian healthcare professional, with post graduate qualifications in nursing, midwifery, wound care and sexology. Melissa's dual qualifications as a Sexologist and Nurse Practitioner uniquely position her and her team to address both the physical and complex psychological aspects of men's sexual health conditions. As the director of a sexual clinic, Melissa and her clinical team work across four clinics, servicing metropolitan Perth and reaching as far as the beautiful Southwest Region.